This virtual series was created in collaboration with the MidAtlantic AETC Ending the HIV Epidemic (EHE) Workgroup. This comprehensive webinar series aims to provide healthcare professionals with the latest strategies and tools to end the HIV epidemic. Each training session will focus on one of the four key strategies that make up the Ending the HIV Epidemic U.S. Initiative, which include: diagnosing all individuals with HIV as early as possible, treating HIV rapidly and effectively to achieve sustained viral suppression, preventing new HIV transmissions using proven interventions such as PrEP, and responding quickly to potential HIV outbreaks to get needed prevention and treatment services to those who need them.
For more information on this series, visit: https://www.maaetc.org/p/ehemaaetc
This program will address the elements of the key strategy: Diagnosis.
Speaker:
Kate Scott, DNP, CRNP, MPH
Assistant Professor
University of Maryland School of Nursing
Objectives:
Upon completion of this course, participants will be able to:
- Define status-neutral care and its role in HIV treatment, care, and prevention
- Describe effective communication strategies for discussing HIV status and linkage to care.
- Discuss the various types of stigma that can be experienced and how they can act as barriers to HIV diagnosis.
- Identify non-stigmatizing approaches to discussing STI/HIV testing, treatment, and prevention with patients.
Acknowledgement:
The MidAtlantic AIDS Education and Training Center (MAAETC) is supported by DHHS, Health Resources and Services Administration (HRSA) as part of a cooperative agreement of $2,917,621 and 0% financed with non-governmental sources. Additional funding provided by the Pennsylvania Department of Health (PA DOH), Bureau of Communicable Diseases, Division of HIV Disease. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade names for products mentioned are for training and identification purposes only. The contents of this material are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. Funding was made possible in part by TR7HA53201-01-00 from the HRSA, HIV/AIDS Bureau. For more information, please visit HRSA.gov.
